Portfolio company
Ventuno Biotech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops cancer immunotherapies to stimulate the immune system and treat patients with difficult tumours.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vivere Oncotherapies
This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.
Bioarchitech
This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.
Stratosvir
This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.
Swarm Oncology
This biotechnology company develops personalised T cell therapies for patients with advanced solid cancers to achieve long-term remission.
Ayuvant
The company develops RNA nanoparticle immunotherapies to treat cancer patients who do not respond to existing immune checkpoint inhibitors.
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
PanCancerT
This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.
OverT
This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.
